Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 19Recruiting 10Terminated 8Unknown 7Active not recruiting 4Withdrawn 3Not yet recruiting 3

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 3

Conditions

Oligometastatic Prostate Carcinoma 1Oligo-metastatic Prostate Carcinoma 1Metastatic Hormone-Sensitive Prostate Cance 1

Interventions

Drug Therapy 107Cisplatin 97Radiotherapy 89Carboplatin 87Bevacizumab 79Oxaliplatin 74tislelizumab 68Capecitabine 68Gemcitabine 64Cyclophosphamide 64toripalimab 62Paclitaxel 57pembrolizumab 55sintilimab 53Specimen Handling 53Surgical Procedures, Operative 52anlotinib 49Fluorouracil 49Magnetic Resonance Spectroscopy 48Immune Checkpoint Inhibitors 43Blood Specimen Collection 42130-nm albumin-bound paclitaxel 42Standard of Care 38camrelizumab 36fludarabine 35lenvatinib 34Leucovorin 34venetoclax 30Radiosurgery 30Immunotherapy 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × abiraterone × Clear all
NCT07154914 2025-09-04

A Novel Insight Into CRPC Progression and Immune: Evidence From Single-cell Spatial Transcriptome Multi-omics

Anhui Medical University

Not yet recruiting
396 enrolled
Genitourinary

Metastatic Hormone-Sensitive Prostate Cance

NCT05707468 2024-02-20

Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer

Changhai Hospital

Phase NA Not yet recruiting
200 enrolled
Genitourinary

Oligometastatic Prostate Carcinoma

NCT06198387 2024-01-10

Radiotherapy for Prostate and Oligo-metastatic Lesions in Patients With Low-burden Oligo-metastatic Prostate Cancer

Changhai Hospital

Phase NA Not yet recruiting
30 enrolled
Genitourinary

Oligo-metastatic Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡